Intravenous Fibrinolysis Eligibility: A Survey of Stroke Clinicians' Practice Patterns and Review of the Literature
De Los Rios F, Kleindorfer D, Guzik A, Ortega-Gutierrez S, Sangha N, Kumar G, Grotta J, Lee J, Meyer B, Schwamm L, Khatri P, Investigators S. Intravenous Fibrinolysis Eligibility: A Survey of Stroke Clinicians' Practice Patterns and Review of the Literature. Journal Of Stroke And Cerebrovascular Diseases 2014, 23: 2130-2138. PMID: 25113084, PMCID: PMC4157964, DOI: 10.1016/j.jstrokecerebrovasdis.2014.03.024.Peer-Reviewed Original ResearchConceptsStroke cliniciansPractice patternsEligible patientsSymptom onsetEuropean Cooperative Acute Stroke Study-III criteriaIntravenous recombinant tissue plasminogen activator useCurrent American Heart Association guidelinesRecombinant tissue plasminogen activator useTissue plasminogen activator useAmerican Heart Association guidelinesHealth Stroke ScaleHeart Association guidelinesHour time frameClinician practice patternsNational InstituteSevere strokeStroke ScaleIschemic strokeMild strokeAssociation guidelinesMost cliniciansElderly individualsEligibility criteriaDrug AdministrationInvestigator meetingUse of Renin–Angiotensin System Blockers in Acute Coronary Syndromes
Bainey K, Armstrong P, Fonarow G, Cannon C, Hernandez A, Peterson E, Peacock W, Laskey W, Zhao X, Schwamm L, Bhatt D. Use of Renin–Angiotensin System Blockers in Acute Coronary Syndromes. Circulation Cardiovascular Quality And Outcomes 2014, 7: 227-235. PMID: 24569634, DOI: 10.1161/circoutcomes.113.000422.Peer-Reviewed Original ResearchConceptsAngiotensin receptor blockersAcute coronary syndromeACEI/angiotensin receptor blockerACEI/ARB therapyCoronary artery bypassCoronary syndromeAmerican CollegeARB therapyArtery bypassRenal insufficiencyMyocardial infarctionCardiology/American Heart Association class ICardiology/American Heart Association guidelinesGuidelines-Coronary Artery Disease programHospital coronary artery bypassRenin-angiotensin system blockersAmerican Heart Association guidelinesU.S. National RegistryHeart Association guidelinesRate of treatmentQuality improvement effortsEligible patientsSystem blockersReceptor blockersHospital discharge